• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算机的基因优先级分析突出了骨形态发生蛋白 4 () 启动子甲基化在结直肠癌所有甲基化簇中的重要性。

In Silico Gene Prioritization Highlights the Significance of Bone Morphogenetic Protein 4 () Promoter Methylation across All Methylation Clusters in Colorectal Cancer.

机构信息

Agricultural Institute of Slovenia, Hacquetova ulica 17, SI-1000 Ljubljana, Slovenia.

Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia.

出版信息

Int J Mol Sci. 2023 Aug 11;24(16):12692. doi: 10.3390/ijms241612692.

DOI:10.3390/ijms241612692
PMID:37628872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454928/
Abstract

The cytosine-phosphate-guanine (CpG) island methylator phenotype (CIMP) represents one of the pathways involved in the development of colorectal cancer, characterized by genome-wide hypermethylation. To identify samples exhibiting hypermethylation, we used unsupervised hierarchical clustering on genome-wide methylation data. This clustering analysis revealed the presence of four distinct subtypes within the tumor samples, namely, CIMP-H, CIMP-L, cluster 3, and cluster 4. These subtypes demonstrated varying levels of methylation, categorized as high, intermediate, and very low. To gain further insights, we mapped significant probes from all clusters to Ensembl Regulatory build 89, with a specific focus on those located within promoter regions or bound regions. By intersecting the methylated promoter and bound regions across all methylation subtypes, we identified a total of 253 genes exhibiting aberrant methylation patterns in the promoter regions across all four subtypes of colorectal cancer. Among these genes, our comprehensive genome-wide analysis highlights bone morphogenic protein 4 () as the most prominent candidate. This significant finding was derived through the utilization of various bioinformatics tools, emphasizing the potential role of in colorectal cancer development and progression.

摘要

胞嘧啶-磷酸-鸟嘌呤(CpG)岛甲基化表型(CIMP)是结直肠癌发生发展的途径之一,其特征是全基因组超甲基化。为了鉴定表现出高甲基化的样本,我们使用无监督层次聚类对全基因组甲基化数据进行了分析。该聚类分析显示,肿瘤样本中存在四种不同的亚型,分别为 CIMP-H、CIMP-L、cluster 3 和 cluster 4。这些亚型表现出不同程度的甲基化,分为高、中、低三种。为了进一步深入研究,我们将所有聚类的显著探针映射到 Ensembl Regulatory build 89,特别关注位于启动子区域或结合区域的探针。通过在所有甲基化亚型中交叉比较甲基化启动子和结合区域,我们总共鉴定到了 253 个在结直肠癌的四个亚型中都表现出启动子区域异常甲基化模式的基因。在这些基因中,我们的全基因组综合分析突出了骨形态发生蛋白 4()作为最主要的候选基因。这一重要发现是通过利用各种生物信息学工具得出的,强调了在结直肠癌的发生和发展过程中可能存在的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/309def261033/ijms-24-12692-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/336c61dc2190/ijms-24-12692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/b7d94235d7c6/ijms-24-12692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/e328b15809ea/ijms-24-12692-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/309def261033/ijms-24-12692-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/336c61dc2190/ijms-24-12692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/b7d94235d7c6/ijms-24-12692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/e328b15809ea/ijms-24-12692-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d44/10454928/309def261033/ijms-24-12692-g004.jpg

相似文献

1
In Silico Gene Prioritization Highlights the Significance of Bone Morphogenetic Protein 4 () Promoter Methylation across All Methylation Clusters in Colorectal Cancer.基于计算机的基因优先级分析突出了骨形态发生蛋白 4 () 启动子甲基化在结直肠癌所有甲基化簇中的重要性。
Int J Mol Sci. 2023 Aug 11;24(16):12692. doi: 10.3390/ijms241612692.
2
Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.全基因组甲基化分析确定了CIMP-H型结直肠癌中一组核心的高甲基化基因。
BMC Cancer. 2017 Mar 28;17(1):228. doi: 10.1186/s12885-017-3226-4.
3
Genome-scale analysis of aberrant DNA methylation in colorectal cancer.结直肠癌中异常 DNA 甲基化的全基因组分析。
Genome Res. 2012 Feb;22(2):271-82. doi: 10.1101/gr.117523.110. Epub 2011 Jun 9.
4
Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.基于 DNA 甲基化分析的结直肠癌 CIMP 与 BRAF 相关性分析。
PLoS One. 2009 Dec 21;4(12):e8357. doi: 10.1371/journal.pone.0008357.
5
Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.全面分析结直肠癌中的 DNA 甲基化,揭示具有不同临床病理和分子特征的亚群。
BMC Cancer. 2010 May 21;10:227. doi: 10.1186/1471-2407-10-227.
6
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.通过定量DNA甲基化分析对结直肠癌中病理特征与CpG岛甲基化表型(CIMP)的相关性研究
Am J Surg Pathol. 2006 Sep;30(9):1175-83. doi: 10.1097/01.pas.0000213266.84725.d0.
7
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.具有CpG岛甲基化表型的MLH1甲基化和未甲基化结直肠癌之间的不同特征:对锯齿状肿瘤形成途径的影响
Oncotarget. 2016 Mar 22;7(12):14095-111. doi: 10.18632/oncotarget.7374.
8
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.与MGMT启动子甲基化和沉默相关的分子支持结直肠癌中的低CpG岛甲基化表型(CIMP-low)。
Gut. 2007 Nov;56(11):1564-71. doi: 10.1136/gut.2007.119750. Epub 2007 Mar 5.
9
The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.CpG岛甲基化表型与结直肠癌中的长程表观遗传沉默相关。
Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.
10
Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.3p22 区域包含 MLH1 的甲基化是结直肠癌 CpG 岛甲基化表型的代表。
Mod Pathol. 2011 Mar;24(3):396-411. doi: 10.1038/modpathol.2010.212. Epub 2010 Nov 19.

本文引用的文献

1
Recent developments on BMPs and their antagonists in inflammatory bowel diseases.骨形态发生蛋白及其拮抗剂在炎症性肠病中的最新进展
Cell Death Discov. 2023 Jul 1;9(1):210. doi: 10.1038/s41420-023-01520-z.
2
Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.通过综合生物信息学分析鉴定结肠炎相关结肠癌的枢纽基因和通路。
BMC Genom Data. 2022 Jun 22;23(1):48. doi: 10.1186/s12863-022-01065-7.
3
Bone Morphogenetic Protein 4 Alleviates DSS-Induced Ulcerative Colitis Through Activating Intestinal Stem Cell by Target ID3.
骨形态发生蛋白4通过靶向ID3激活肠道干细胞减轻右旋糖酐硫酸钠诱导的溃疡性结肠炎。
Front Cell Dev Biol. 2021 Oct 6;9:700864. doi: 10.3389/fcell.2021.700864. eCollection 2021.
4
Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening.结直肠癌基因在结直肠前病变和肿瘤组织中的甲基化谱:筛查的观点。
Scand J Gastroenterol. 2021 Aug;56(8):920-928. doi: 10.1080/00365521.2021.1922744. Epub 2021 Jul 3.
5
Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration.Grem1 通过骨形态发生蛋白通路拮抗作用调节肠道再生中的上皮细胞命运。
Gastroenterology. 2021 Jul;161(1):239-254.e9. doi: 10.1053/j.gastro.2021.03.052. Epub 2021 Apr 2.
6
Hypermethylated promoters of genes and as potential novel diagnostic biomarkers in colorectal cancer.基因 和 的高甲基化启动子作为结直肠癌潜在的新型诊断生物标志物。
Epigenomics. 2020 Oct;12(19):1677-1688. doi: 10.2217/epi-2020-0118. Epub 2020 Oct 20.
7
Androgen Maintains Intestinal Homeostasis by Inhibiting BMP Signaling via Intestinal Stromal Cells.雄激素通过肠基质细胞抑制 BMP 信号维持肠道内稳态。
Stem Cell Reports. 2020 Oct 13;15(4):912-925. doi: 10.1016/j.stemcr.2020.08.001. Epub 2020 Sep 10.
8
BMP-9 is a novel marker for colorectal tumorigenesis undergoing the normal mucosa-adenoma-adenocarcinoma sequence and is associated with colorectal cancer prognosis.骨形态发生蛋白-9是经历正常黏膜-腺瘤-腺癌序列的结直肠癌发生的一种新型标志物,且与结直肠癌预后相关。
Oncol Lett. 2020 Jan;19(1):271-282. doi: 10.3892/ol.2019.11125. Epub 2019 Nov 19.
9
The integrative knowledge base for miRNA-mRNA expression in colorectal cancer.结直肠癌中 miRNA-mRNA 表达的综合知识库。
Sci Rep. 2019 Dec 2;9(1):18065. doi: 10.1038/s41598-019-54358-w.
10
Epigenetic heterogeneity in cancer.癌症中的表观遗传异质性。
Biomark Res. 2019 Oct 31;7:23. doi: 10.1186/s40364-019-0174-y. eCollection 2019.